Global Patent Index - EP 1317562 A2

EP 1317562 A2 2003-06-11 - TEST SYSTEMS BASED ON TRANSMEMBRANE RECEPTORS FROM HELMINTHS AND THE USE THEREOF FOR IDENTIFYING AND CHARACTERIZING COMPOUNDS

Title (en)

TEST SYSTEMS BASED ON TRANSMEMBRANE RECEPTORS FROM HELMINTHS AND THE USE THEREOF FOR IDENTIFYING AND CHARACTERIZING COMPOUNDS

Title (de)

AUF TRANSMEMBRANREZEPTOREN AUS HELMINTHEN BASIERENDE TESTSYSTEME UND DEREN VERWENDUNG ZUR IDENTIFIZIERUNG UND CHARAKTERISIERUNG VON VERBINDUNGEN

Title (fr)

SYSTEMES DE TEST BASES SUR DES TRANSMEMBRANE RECEPTEURS DE HELMINTHS ET LEUR UTILISATION POUR L'IDENTIFICATION ET LA CARACTERISATION DE COMPOSES

Publication

EP 1317562 A2 (DE)

Application

EP 01974211 A

Priority

  • DE 10044098 A
  • DE 10053785 A
  • EP 0109771 W

Abstract (en)

[origin: WO0220830A2] The invention relates to test systems that are based on transmembrane receptors from helminths and arthropods and to their use for identifying and characterizing substances that are effective against helminths, arthropods or that have an effect on the calcium metabolism of organisms and/or cells. The invention further relates to the use of a specific ligand in said test system and to the use thereof as an anthelminthic or arthropodan active substance.

IPC 1-7 (main, further and additional classification)

C12Q 1/25; C07K 14/435; C12N 15/00; C12Q 1/02; C12Q 1/68

IPC 8 full level (invention and additional information)

A01K 67/033 (2006.01); A01N 63/00 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61P 33/10 (2006.01); C07K 14/435 (2006.01); C07K 14/705 (2006.01); C07K 14/72 (2006.01); C07K 16/28 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 33/68 (2006.01)

CPC (invention and additional information)

G01N 33/502 (2013.01); C07K 14/4354 (2013.01); C07K 14/705 (2013.01); C07K 14/723 (2013.01); C12Q 1/6888 (2013.01); G01N 33/5008 (2013.01); G01N 33/5014 (2013.01); G01N 33/5085 (2013.01); G01N 33/5308 (2013.01); G01N 33/6872 (2013.01); G01N 2333/4353 (2013.01); G01N 2333/4719 (2013.01); G01N 2333/705 (2013.01)

Citation (search report)

See references of WO 0220830A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

EPO simple patent family

WO 0220830 A2 20020314; WO 0220830 A3 20020725; AU 9378901 A 20020322; CA 2421248 A1 20020314; CN 1543508 A 20041103; EP 1317562 A2 20030611; JP 2004508052 A 20040318; NZ 524533 A 20050429

INPADOC legal status


2006-03-15 [18D] APPLICATION DEEMED TO BE WITHDRAWN

- Effective date: 20050907

2005-06-08 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20050426

2004-01-02 [RAP1] TRANSFER OF RIGHTS OF AN APPLICATION

- Owner name: BAYER HEALTHCARE AG

2003-06-11 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20030407

2003-06-11 [AK] DESIGNATED CONTRACTING STATES:

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

2003-06-11 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO:

- Countries: AL LT LV MK RO SI